Gene · 3239
Papers1,817
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
261 to 280 of 1,817
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Checkpoint Inhibitor-Associated Scleroderma and Scleroderma Mimics. | Pharmaceuticals (Basel) | 2023 | 37259404 | PubTator, text mining | PubMed |
| Serum immune mediators as novel predictors of response to anti-PD-1/PD-L1 therapy in non-small cell lung cancer patients with high tissue-PD-L1 expression. | Front Immunol | 2023 | 37256148 | PubTator, text mining | PubMed |
| Prediction of risk and overall survival of pancreatic cancer from blood soluble immune checkpoint-related proteins. | Front Immunol | 2023 | 37256126 | PubTator, text mining | PubMed |
| The upper and lower respiratory tract microbiome in severe aspiration pneumonia. | iScience | 2023 | 37250794 | PubTator, text mining | PubMed |
| In Silico Subtractive Proteomics and Molecular Docking Approaches for the Identification of Novel Inhibitors against Streptococcus pneumoniae Strain D39. | Life (Basel) | 2023 | 37240772 | PubTator, text mining | PubMed |
| Whole Blood Spermine/Spermidine Ratio as a New Indicator of Sarcopenia Status in Older Adults. | Biomedicines | 2023 | 37239074 | PubTator, text mining | PubMed |
| Immune correlates with response in patients with metastatic solid tumors treated with a tumor targeting immunocytokine NHS-IL12. | Int Immunopharmacol | 2023 | 37234190 | PubTator, text mining | PubMed |
| The role of fibroblast growth factor 18 in cancers: functions and signaling pathways. | Front Oncol | 2023 | 37228502 | PubTator, text mining | PubMed |
| Diagnostic testing for interstitial lung disease in common variable immunodeficiency: a systematic review. | Front Immunol | 2023 | 37223103 | PubTator, text mining | PubMed |
| Local Delivery of Immunomodulatory Antibodies for Gastrointestinal Tumors. | Cancers (Basel) | 2023 | 37190279 | PubTator, text mining | PubMed |
| Circulating immune checkpoints predict heart failure outcomes. | ESC Heart Fail | 2023 | 37186066 | PubTator, text mining | PubMed |
| Low plasma PD-L1 levels, early tumor onset and absence of peritoneal carcinomatosis improve prognosis of women with advanced high-grade serous ovarian cancer. | BMC Cancer | 2023 | 37179293 | PubTator, text mining | PubMed |
| Immune Checkpoint Profiling in Humanized Breast Cancer Mice Revealed Cell-Specific LAG-3/PD-1/TIM-3 Co-Expression and Elevated PD-1/TIM-3 Secretion. | Cancers (Basel) | 2023 | 37174080 | PubTator, text mining | PubMed |
| The changing epidemiology of syndactyly in Chinese newborns: a nationwide surveillance-based study. | BMC Pregnancy Childbirth | 2023 | 37165329 | PubTator, text mining | PubMed |
| Two putative glutamate decarboxylases of Streptococcus pneumoniae as possible antigens for the production of anti-GAD65 antibodies leading to type 1 diabetes mellitus. | Int Microbiol | 2023 | 37154976 | PubTator, text mining | PubMed |
| Genomic Diversity of Methicillin-Resistant Staphylococcus aureus CC398 Isolates Collected from Diseased Swine in the German National Resistance Monitoring Program GERM-Vet from 2007 to 2019. | Microbiol Spectr | 2023 | 37154741 | PubTator, text mining | PubMed |
| KMT2D Deficiency Promotes Myeloid Leukemias which Is Vulnerable to Ribosome Biogenesis Inhibition. | Adv Sci (Weinh) | 2023 | 37142882 | PubTator, text mining | PubMed |
| Construction of a novel molecular typing and scoring system for anoikis distinguishes between different prognostic risks and treatment responsiveness in low-grade glioma. | Front Immunol | 2023 | 37114037 | PubTator, text mining | PubMed |
| PGE2 Produced by Exogenous MSCs Promotes Immunoregulation in ARDS Induced by Highly Pathogenic Influenza A through Activation of the Wnt-β-Catenin Signaling Pathway. | Int J Mol Sci | 2023 | 37108459 | PubTator, text mining | PubMed |
| Immune drivers of HBsAg loss in HBeAg-negative CHB patients after stopping nucleotide analog and administration of Peg-IFN. | Hepatol Commun | 2023 | 37102765 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/3239/papers?page=14